1.Shankar V, Baghdayan AS, Huycke MM, Lindahl G, Gilmore MS: Infection-derived Enterococcus faecalisstrains are enriched in esp, a gene encoding a novel surface protein. Infect Immun 1999, 67(1):193–200.
2.Vankerckhoven V, Van Autgaerden T, Vael C, Lammens C, Chapelle S, Rossi R, Jabes D, Goossens H: Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol 2004, 42(10):4473–4479.
3.Bourgogne A, Singh KV, Fox KA, Pflughoeft KJ, Murray BE, Garsin DA: EbpR is important for biofilm formation by activating expression of the endocarditis and biofilm-associated pilus operon (ebpABC) of Enterococcus faecalis OG1RF. J Bacteriol 2007, 189(17):6490–6493.
4.Tannock GW, Cook G: Enterococci as members of the intestinal microflora of humans. In: The Enterococci. American Society of Microbiology; 2002: 101–132.
5.Lowe A, Lambert P, Smith A: Cloning of an Enterococcus faecalis endocarditis antigen: homology with adhesins from some oral streptococci. Infect Immun 1995, 63(2):703–706.
6.Mohamed JA, Huang W, Nallapareddy SR, Teng F, Murray BE: Influence of origin of isolates, especially endocarditis isolates, and various genes on biofilm formation by Enterococcus faecalis. Infect Immun 2004, 72(6):3658–3663.
7.Baldassarri L, Creti R, Recchia S, Pataracchia M, Alfarone G, Orefici G, Campoccia D, Montanaro L, Arciola CR: Virulence factors in enterococcal infections of orthopedic devices. The International journal of artificial organs 2006, 29(4):402–406.
8.Gomes BPFA, Pinheiro ET, Sousa ELR, Jacinto RC, Zaia AA, Ferraz CCR, de Souza-Filho FJ: Enterococcus faecalis in dental root canals detected by culture and by polymerase chain reaction analysis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2006, 102(2):247–253.
9.Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK: NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008, 29(11):996–1011.
10.Nallapareddy SR, Murray BE: Ligand-signaled upregulation of Enterococcus faecalis ace transcription, a mechanism for modulating host-E. faecalis interaction. Infect Immun 2006, 74(9):4982–4989.
11.Gilmore MS, Segarra RA, Booth MC, Bogie CP, Hall LR, Clewell DB: Genetic structure of the Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to lantibiotic determinants. J Bacteriol 1994, 176(23):7335–7344.
12.Jett BD, Huycke MM, Gilmore MS: Virulence of enterococci. Clin Microbiol Rev 1994, 7(4):462–478.
13.Su Y, Sulavik M, He P, Makinen K, Makinen P-L, Fiedler S, Wirth R, Clewell D: Nucleotide sequence of the gelatinase gene (gelE) from Enterococcus faecalis subsp. liquefaciens. Infect Immun 1991, 59(1):415–420.
14.Palmer KL, Gilmore MS: Multidrug-resistant enterococci lack CRISPR-cas. MBio 2010, 1(4):e00227–00210.
15.Eaton TJ, Gasson MJ: Molecular screening of Enterococcusvirulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol 2001, 67(4):1628–1635.
16.Galli D, Lottspeich F, Wirth R: Sequence analysis of Enterococcus faecalis aggregation substance encoded by the sex pheromone plasmid pAD1. Mol Microbiol 1990, 4(6):895–904.
17.Nallapareddy SR, Qin X, Weinstock GM, Höök M, Murray BE: Enterococcus faecalis adhesin, ace, mediates attachment to extracellular matrix proteins collagen type IV and laminin as well as collagen type I. Infect Immun 2000, 68(9):5218–5224.
18.Grissa I, Vergnaud G, Pourcel C: The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics 2007, 8(1):172.
19.Makarova KS, Haft DH, Barrangou R, Brouns SJ, Charpentier E, Horvath P, Moineau S, Mojica FJ, Wolf YI, Yakunin AF: Evolution and classification of the CRISPR–Cas systems. Nature Reviews Microbiology 2011, 9(6):467–477.
20.Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, Snijders AP, Dickman MJ, Makarova KS, Koonin EV, Van Der Oost J: Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 2008, 321(5891):960–964.
21.Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P: CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007, 315(5819):1709–1712.
22.Makarova KS, Grishin NV, Shabalina SA, Wolf YI, Koonin EV: A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct 2006, 1(1):7.
23.Bourgogne A, Garsin DA, Qin X, Singh KV, Sillanpaa J, Yerrapragada S, Ding Y, Dugan-Rocha S, Buhay C, Shen H: Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RF. Genome Biol 2008, 9(7):R110.
24.Haft DH, Selengut J, Mongodin EF, Nelson KE: A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes. PLoS Comput Biol 2005, 1(6):e60.
25.Marraffini LA, Sontheimer EJ: CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA. Science 2008, 322(5909):1843–1845.
26.Pourcel C, Salvignol G, Vergnaud G: CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 2005, 151(3):653–663.
27.Gholizadeh P, Aghazadeh M, Asgharzadeh M, Kafil HS: Suppressing the CRISPR/Cas adaptive immune system in bacterial infections. Eur J Clin Microbiol Infect Dis 2017, 36(11):2043–2051.
28.Facklam R, Collins M: Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989, 27(4):731–734.
29.Kariyama R, Mitsuhata R, Chow JW, Clewell DB, Kumon H: Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. J Clin Microbiol 2000, 38(8):3092–3095.
30.Kafil HS, Mobarez AM: Assessment of biofilm formation by enterococci isolates from urinary tract infections with different virulence profiles. Journal of King Saud University-Science 2015, 27(4):312–317.
31.Gaspar F, Crespo M, Lopes MS: Proposal for a reliable enterococcal cytolysin production assay avoiding apparent incongruence between phenotype and genotype. J Med Microbiol 2009, 58(8):1122–1124.
32.Pickett M, Greenwood J, Harvey S: Tests for detecting degradation of gelatin: comparison of five methods. J Clin Microbiol 1991, 29(10):2322–2325.
33.Burley KM, Sedgley CM: CRISPR-Cas, a Prokaryotic Adaptive Immune System, in Endodontic, Oral, and Multidrug-resistant Hospital-acquired Enterococcus faecalis. J Endod 2012, 38(11):1511–1515.
34.Hew CM, Korakli M, Vogel RF: Expression of virulence-related genes by Enterococcus faecalis in response to different environments. Syst Appl Microbiol 2007, 30(4):257–267.
35.Martin B, Garriga M, Hugas M, Aymerich T: Genetic diversity and safety aspects of enterococci from slightly fermented sausages. J Appl Microbiol 2005, 98(5):1177–1190.
36.Shankar N, Coburn P, Pillar C, Haas W, Gilmore M: Enterococcal cytolysin: activities and association with other virulence traits in a pathogenicity island. Int J Med Microbiol 2004, 293(7):609–618.
37.Shankar N, Lockatell CV, Baghdayan AS, Drachenberg C, Gilmore MS, Johnson DE: Role of Enterococcus faecalissurface protein ESP in the pathogenesis of ascending urinary tract infection. Infect Immun 2001, 69(7):4366–4372.
38.Duggan JM, Sedgley CM: Biofilm Formation of Oral and Endodontic Enterococcus faecalis. J Endod 2007, 33(7):815–818.
39.Sun J, Sundsfjord A, Song X: Enterococcus faecalis from patients with chronic periodontitis: virulence and antimicrobial resistance traits and determinants. Eur J Clin Microbiol Infect Dis 2012, 31(3):267–272.
40.Sedgley CM, Molander A, Flannagan SE, Nagel AC, Appelbe OK, Clewell DB, Dahlén G: Virulence, phenotype and genotype characteristics of endodontic Enterococcus spp. Oral Microbiol Immunol 2005, 20(1):10–19.
41.Lindenstrauß AG, Pavlovic M, Bringmann A, Behr J, Ehrmann MA, Vogel RF: Comparison of genotypic and phenotypic cluster analyses of virulence determinants and possible role of CRISPR elements towards their incidence in Enterococcus faecalis and Enterococcus faecium. Syst Appl Microbiol 2011, 34(8):553–560.
42.Finlay BB, Falkow S: Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev 1997, 61(2):136–169.
43.Palmer KL, Carniol K, Manson JM, Heiman D, Shea T, Young S, Zeng Q, Gevers D, Feldgarden M, Birren B: High-quality draft genome sequences of 28 Enterococcus sp. isolates. J Bacteriol 2010, 192(9):2469–2470.
44.Toro M, Cao G, Ju W, Allard M, Barrangou R, Zhao S, Brown E, Meng J: Association of clustered regularly interspaced short palindromic repeat (CRISPR) elements with specific serotypes and virulence potential of Shiga toxin-producing Escherichia coli. Appl Environ Microbiol 2014, 80(4):1411–1420.
45.Touchon M, Charpentier S, Pognard D, Picard B, Arlet G, Rocha EP, Denamur E, Branger C: Antibiotic resistance plasmids spread among natural isolates of Escherichia coli in spite of CRISPR elements. Microbiology 2012, 158(12):2997–3004.
46.Godde JS, Bickerton A: The repetitive DNA elements called CRISPRs and their associated genes: evidence of horizontal transfer among prokaryotes. J Mol Evol 2006, 62(6):718–729.